Lawsuit Overview
<p align= justify >According to a press release dated August 13, 2007, the complaint charges Northwest Biotherapeutics and certain of its officers and directors with violations of the Exchange Act. Northwest Biotherapeuticsis a development stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance i...
You must register (for free) or login to view the entire case.